ENKA İNŞAAT VE SANAYİ
ANONİM ŞİRKETİ
AND ITS SUBSIDIARIES
Condensed Consolidated Interim Financial
Statements as at and for the Three-Months
Period Ended
31 March 2023
TABLE OF CONTENTS | PAGE |
CONDENSED CONSOLIDATED INTERIM STATEMENT OF FINANCIAL POSITION | 1-2 | |
CONDENSED CONSOLIDATED INTERIM STATEMENT OF PROFIT OR LOSS | 3 | |
CONDENSED CONSOLIDATED INTERIM STATEMENT OF OTHER COMPREHENSIVE INCOME | 4 | |
CONDENSED CONSOLIDATED INTERIM STATEMENT OF CHANGES IN EQUITY | 5 | |
CONDENSED CONSOLIDATED INTERIM STATEMENT OF CASH FLOWS | 6 | |
NOTES TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS | 7-27 | |
NOTE 1 | ORGANIZATIONS AND OPERATIONS OF THE GROUP | 7 |
NOTE 2 | BASIS OF PRESENTATION OF CONDENSED CONSOLIDATED | |
FINANCIAL STATEMENTS | 8-13 | |
NOTE 3 | CHANGES IN OPERATIONAL SEASON | 13 |
NOTE 4 | SEGMENTAL INFORMATION | 14-16 |
NOTE 5 | CONSTRUCTION CONTRACTS | 17 |
NOTE 6 | INVESTMENT PROPERTY | 17 |
NOTE 7 | PROPERTY, PLANT AND EQUIPMENT | 17 |
NOTE 8 | COMMITMENTS | 18 |
NOTE 9 | RELATED PARTY BALANCES AND TRANSACTIONS | 19 |
NOTE 10 | SHARE CAPITAL AND RESERVES | 19 |
NOTE 11 | INVESTMENT INCOME / EXPENSES | 20 |
NOTE 12 | FINANCIAL RISK MANAGEMENT OBJECTIVES AND POLICIES | 21-24 |
NOTE 13 | FINANCIAL INSTRUMENTS - FAIR VALUE EXPLANATIONS AND | |
ACCOUNTING POLICY FOR HEDGING FINANCIAL RISK | 25-26 | |
NOTE 14 | SUBSEQUENT EVENTS | 26 |
ENKA İNŞAAT VE SANAYİ A.Ş. AND ITS SUBSIDIARIES
CONDENSED CONSOLIDATED INTERIM STATEMENT OF FINANCIAL POSITION AS AT 31 MARCH 2023
(Amounts are expressed in thousands of U.S. Dollars ("USD") unless otherwise stated.)
31 March | 31 December | ||||
ASSETS | Note | 2023 | 2022 | ||
Current Assets | 3,513,231 | 3,536,158 | |||
Cash and cash equivalents | 1,059,241 | 1,026,291 | |||
Financial investments | 13 | 1,470,711 | 1,478,120 | ||
Trade receivables | 278,753 | 312,974 | |||
Other receivables | |||||
Other receivables from related parties | - | - | |||
Other receivables from third parties | 7,399 | 7,146 | |||
Inventories | 336,705 | 372,327 | |||
Prepaid expenses | 264,011 | 232,137 | |||
Costs and estimated earnings in excess of billings | |||||
on uncompleted contracts | 5 | 27,204 | 28,255 | ||
Other current assets | 54,193 | 62,375 | |||
3,498,217 | 3,519,625 | ||||
Assets held for sale | 15,014 | 16,533 | |||
Non-Current Assets | 5,012,432 | 5,044,379 | |||
Financial investments | 13 | 2,176,320 | 2,092,693 | ||
Investment properties | 6 | 1,929,060 | 2,028,224 | ||
Property, plant and equipment | 804,687 | 819,799 | |||
Right of use assets | 59,066 | 59,524 | |||
Intangible assets | |||||
Other intangible assets | 15,933 | 16,487 | |||
Deferred tax assets | 22,455 | 21,563 | |||
Prepaid expenses | 4,813 | 6,021 | |||
Other non-current assets | 98 | 68 | |||
TOTAL ASSETS | 8,525,663 | 8,580,537 | |||
The accompanying notes form an integral part of these condensed consolidated interim financial statements.
1
ENKA İNŞAAT VE SANAYİ A.Ş. AND ITS SUBSIDIARIES
CONDENSED CONSOLIDATED INTERIM STATEMENT OF FINANCIAL POSITION AS AT 31 MARCH 2023
(Amounts are expressed in thousands of U.S. Dollars ("USD") unless otherwise stated.)
31 March | 31 December | ||||
LIABILITIES | Note | 2023 | 2022 | ||
Current Liabilities | 1,324,078 | 1,481,853 | |||
Short-term borrowings | 48,664 | 56,347 | |||
Current portion of long-term borrowings | 4,525 | 4,908 | |||
Trade payables | 335,255 | 451,180 | |||
Payables to employees | 26,688 | 17,427 | |||
Other payables | |||||
Payables to related parties | 6 | 7 | |||
Payables to third parties | 18,180 | 18,546 | |||
Billings in excess of costs and estimated earnings | |||||
on uncompleted contracts | 5 | 397,068 | 423,591 | ||
Deferred income | 347,717 | 358,784 | |||
Taxation on income | 58,052 | 59,001 | |||
Provisions | |||||
Provisions for employee benefits | 9,343 | 9,621 | |||
Other provisions | 41,848 | 42,676 | |||
Other current liabilities | 36,732 | 39,765 |
Non-Current Liabilities | 516,351 | 552,246 |
Long-term borrowings | 118,229 | 127,189 |
Other payables | 22,742 | 24,674 |
Deferred income | 2,144 | 4,528 |
Provisions for employee benefits | 21,214 | 19,218 |
Deferred tax liabilities | 352,022 | 376,637 |
EQUITY | 6,685,234 | 6,546,438 | ||
Equity Attributable to Equity Holders of the Parent | 6,608,258 | 6,471,053 | ||
Share capital | 10 | 2,751,959 | 2,751,959 | |
Treasury Shares | 10 | (126,701) | (127,194) | |
Revaluation surplus | 195,438 | 195,343 | ||
Currency translation difference | (1,421,008) | (1,381,980) | ||
Other reserves | (7,561) | (5,933) | ||
Legal reserves and accumulated profit | 5,216,131 | 5,038,858 | ||
Non-Controlling Interests | 76,976 | 75,385 | ||
TOTAL LIABILITIES AND EQUITY | 8,525,663 | 8,580,537 | ||
The accompanying notes form an integral part of these condensed consolidated interim financial statements.
2
ENKA İNŞAAT VE SANAYİ A.Ş. AND ITS SUBSIDIARIES
CONDENSED CONSOLIDATED INTERIM STATEMENT OF PROFIT OR LOSS FOR THE PERIOD ENDED 31 MARCH 2023
(Amounts are expressed in thousands of U.S. Dollars ("USD") unless otherwise stated.)
1 January- | 1 January- | ||||
31 March | 31 March | ||||
Note | 2023 | 2022 | |||
CONTINUING OPERATIONS | |||||
Revenue | 4 | 927,570 | 822,848 | ||
Cost of revenues (-) | 4 | (746,350) | (628,454) | ||
GROS S PROFIT | 181,220 | 194,394 | |||
Administrative expenses (-) | 4 | (68,753) | (22,094) | ||
M arketing, selling and distribution expenses (-) | 4 | (6,314) | (6,807) | ||
Other operating income | 4 | 21,930 | 6,431 | ||
Other operating expenses (-) | 4 | (9,289) | (10,259) | ||
PROFIT FROM OPERATIONS | 118,794 | 161,665 | |||
Income from investing activities | 4,11 | 233,530 | 69,455 | ||
Expenses from investing activities (-) | 4,11 | (103,788) | (264,304) | ||
OPERATING PROFIT | |||||
BEFORE FINANCE EXPENS ES | 248,536 | (33,184) | |||
Financial income | 4 | 10,729 | 34,785 | ||
Financial expenses (-) | 4 | (25,268) | (9,343) |
PROFIT BEFORE TAX
FROM CONTINUING OPERATIONS
Current tax expense (-)
Deferred tax income / (expense)
NET PROFIT (LOS S ) FOR THE PERIOD
233,997(7,742)
(29,055)(41,637)
6,34913,495
211,291(35,884)
Attributable to: | |||
Non-controlling interest | 9,008 | (619) | |
Equity holders of the parent | 202,283 | (35,265) | |
211,291 | (35,884) | ||
Earning / (Loss) per share from continuing operations | |||
- ordinary share certificate (full USD) | 0.03 | (0.01) | |
Weighted average number of shares | |||
(1 dollar weighted average shares) | 5,862,743,582 | 5,862,743,582 |
The accompanying notes form an integral part of these condensed consolidated interim financial statements.
3
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Enka Insaat ve Sanayi AS published this content on 11 May 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 May 2023 08:26:03 UTC.